Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis

Brain

Volumn 119, Issue 5, 1996, Pages 1717-1727

  Guridi, J ^a,b   Herrero, M T ^a,b   Luquin, M R ^a,b   Guillen J ^a,b   Ruberg, M ^c   Laguna, J ^a,b   Vila, M ^c   Javoy Agid, F ^c   Agid, Y ^c   Hirsch, E ^c   Obeso, J A ^d  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Neurol and Funct Neurosurg Centre   (Spain)

Author keywords

In situ hybridization (GAD); MPTP treatment; Subthalamic nucleus lesion

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTAMATE DECARBOXYLASE; KAINIC ACID; MESSENGER RNA; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BIOCHEMISTRY; BRADYKINESIA; CHOREA; CONTROLLED STUDY; FEMALE; FREEZING; GLOBUS PALLIDUS; HEMIBALLISM; IN SITU HYBRIDIZATION; MACACA; MALE; MESSENGER RNA SYNTHESIS; MONKEY; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS NUCLEUS; TREMOR;

EID: 10344231421     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.5.1717     Document Type: Article

References (77)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders [see comments]. [Review]. Trends Neurosci 1989; 12: 366-75. Comment in: Trends Neurosci 1990; 13: 93-5.
2. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders [see comments]. [Review]. Trends Neurosci 1989; 12: 366-75. Comment in: Trends Neurosci 1990; 13: 93-5.
3. Augood SJ, Emson PC, Mitchell IJ, Boyce S, Clarke CE, Crossman AR. Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys. Mol Brain Res 1989; 6: 85-92.
4. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991; 6: 288-92.
5. Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg 1992; 6: 575-82.
6. Baron MS, Wichmann T, DeLong MR. Inactivation of sensorimotor territory in the internal pallidum reverses parkinsonian signs in MPTP-treated monkeys [abstract]. Soc Neurosci Abstr 1992; 18: 693.
7. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, et al. Stimulation of subthalamic nucleus acutely changes clinical status in Parkinson's disease [abstract]. Soc Neurosci Abstr 1993; 19: 1052.
8. Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993; 5: 382-9.
9. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249: 1436-8.
10. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 507-20.
11. Bisconte J, Fulcrand J, Marty R. Analyse radioautographique dans le système nerveux central par photometric et cartographie combinées. C R Seances Soc Biol Fil 1968; 162: 2178-81.
12. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 1987; 37: 1539-42.
13. Brotchie JM, Mitchell IJ, Sambrook MA, Crossman AR. Alleviation of parkinsonism by antagonism of excitatory aminoacid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 1991; 6: 133-8.
14. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJK, Kaufman DL, Wagner-McPherson CB, et al. Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 1992; 89: 2115-19.
15. Chesselet MF, Weiss L, Wuenschell C, Tobin AJ, Affolter HU. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J Comp Neurol 1987; 262: 125-40.
16. Chevalier G, Deniau JM. Disinhibition as a basic process in the expression of striatal functions. [Review]. Trends Neurosci 1990; 13: 277-80.
17. Crossman AR, Sambrook MA, Jackson A. Experimental hemichorea/ hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain 1984; 107: 579-96.
18. Crossman AR, Mitchell IJ, Sambrook MA. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacology 1985; 24: 587-91.
19. Crossman AR, Sambrook MA, Mitchell IJ, Jackson A, Clarke CE, Robertson RG, et al. Basal ganglia mechanisms mediating experimental dyskinesia in the monkey. In: Carpenter MB, Jayaraman A, editors. The basal ganglia II. Structure and function - current concepts. New York: Plenum Press, 1987: 377-94.
20. Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. Brain 1988: 111: 1211-33.
21. DeLong MR. Primate models of movement disorders of basal ganglia origin. [Review]. Trends Neurosci 1990; 13: 281-5.
22. DeLong MR, Crutcher MD, Georgopoulos AP. Relations between movement and single cell discharge in the substantia nigra of the behaving monkey. J Neurosci 1983; 3: 1599-606.
23. Dierssen G, Gioino G. Correlación anatómica del hemibalismo (sobre 116 casos publicados en la literatura). Rev Clin Esp 1961; 82: 283-305.
24. Dierssen G, Bergmann LL, Gioino G, Cooper IS. Hemiballism following surgery for Parkinson's disease. Arch Neurol 1961; 5: 627-37.
25. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991; 547: 142-51.
26. Fontaine B, Sassoon D, Buckingham M, Changeux JP. Detection of the nicotinic acetylcoline receptor alpha-subunit mRNA by in situ hybridization at neuromuscular junctions of 15-day-old chick striated muscles. EMBO J 1988; 7: 603-9.
27. Gabe M. Techniques histologiques. Paris: Masson, 1968: 903-4.
28. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons [see comments J, Science 1990; 250: 1429-32. Comment in: Science 1991; 253: 332.
29. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons [see comments J, Science 1990; 250: 1429-32. Comment in: Science 1991; 253: 332.
30. Graham WC, Robertson RG, Sambrook MA, Crossman AR. Injection of excitatory amino acid antagonists into the medial pallidal segment of a (MPTP) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treated primate reverses motor symptoms of parkinsonism. Life Sci 1990; 47: PL-91-7.
31. Granata AR, Kitai ST. Inhibitory substantia nigra inputs to the pedunculopontine neurons. Exp Brain Res 1991; 86: 459-66.
32. Graybiel AM, Hirsch EC, Agid YA. Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc Natl Acad Sci USA 1987; 84: 303-7.
33. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease [see comments]. [Review]. Mov Disord 1993; 8: 421-9. Comment in: Mov Disord 1994; 9: 470-2.
34. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease [see comments]. [Review]. Mov Disord 1993; 8: 421-9. Comment in: Mov Disord 1994; 9: 470-2.
35. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992; 68: 1850-8.
36. Hazrati LN, Parent A. Contralateral pallidothalamic and pallidotegmental projections in primates: an anterograde and retrograde labeling study. Brain Res 1991; 567: 212-23.
37. Herrero MT, Ruberg M, Hirsch EC, Mouatt A, Tobin AJ, Agid Y, et al. In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci Lett 1993a; 157: 57-61.
38. Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, et al. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 1993b; 56: 499-511.
39. Herrero MT, Augood SJ, Hirsch EC, Javoy-Agid, Luquin MR, Agid Y. et al. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 1995; 68: 1189-98.
40. Hikosaka O, Wurtz RH. Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. J Neurophysiol 1983; 49: 1285-301.
41. Iacono RP, Lonser R, Morenski JD. Movement disorders stereotactic surgery for Parkinson's disease [letter; comment]. Mov Disord 1994; 9: 470-2. Comment on: Mov Disord 1993; 8: 421-9.
42. Iacono RP, Lonser R, Morenski JD. Movement disorders stereotactic surgery for Parkinson's disease [letter; comment]. Mov Disord 1994; 9: 470-2. Comment on: Mov Disord 1993; 8: 421-9.
43. Inzelberg R, Korczyn A. Persistent hemiballism in Parkinson's disease [letter; see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 1013-14. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 645-7.
44. Inzelberg R, Korczyn A. Persistent hemiballism in Parkinson's disease [letter; see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 1013-14. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 645-7.
45. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 1990; 38: 245-53.
46. Kulisevsky J, Lima de Freitas M, Barraquer-Bordas L. Bilateral akinesia in drug-induced parkinsonism after a subthalamic lesion [letter]. Mov Disord 1994; 9: 111-12.
47. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease [see comments]. J Neurosurg 1992; 76: 53-61. Comment in: J Neurosurg 1992; 77: 487-8.
48. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease [see comments]. J Neurosurg 1992; 76: 53-61. Comment in: J Neurosurg 1992; 77: 487-8.
49. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas J-F, Broussolle E, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345: 91-5.
50. Litwak J, Mercugliano M, Chesselet M-F, Oltmans GA. Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing. Neurosci Lett 1990; 116: 179-83.
51. Luquin MR, Laguna J, Obeso JA. Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys. Ann Neurol 1992; 31: 551-4.
52. Luquin MR, Laguna J, Herrero MT, Obeso JA. Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys. J Neurol Sci 1993; 114: 40-4.
53. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease [see comments]. [Review]. Brain 1994; 117: 877-97. Comment in: Brain 1995; 118: 822.
54. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease [see comments]. [Review]. Brain 1994; 117: 877-97. Comment in: Brain 1995; 118: 822.
55. Marsden CD. Parkes JP, Quinn N. Fluctuations of disability in Parkinson's disease. Clinical aspects. In: Marsden CD, Fahn S, editors. Movement Disorders. London: Butterworth, 1982: 96-122.
56. Martin JP, Alcock NS. Hemichorea associated with a lesion of the corpus Luysii. Brain 1934; 57: 504-16.
57. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. [Review]. J Neurochem 1993; 60: 395-407.
58. Mercugliano M, Soghomonian J-J, Qin Y, Nguyen HQ, Feldblum S, Erlander MG, et al. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J Comp Neurol 1992; 318: 245-54.
59. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A, editors. The basal ganglia II. New York: Plenum Press, 1987: 415-27.
60. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs P, Sambrook MA, et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1989; 32: 213-26.
61. Mitchell IJ, Boyce S, Sambrook MA, Crossman AR. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain 1992; 115: 809-24.
62. Mora F, Mogenson GJ, Rolls ET. Activity of neurons in the region of the substantia nigra during feeding in the monkey. Brain Res 1977; 133: 267-76.
63. Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. [Review]. Neurology 1989; 39 (11 Suppl 2): 11-19.
64. Obeso JA, Guridi J, Herrero MT. Role of the subthalamic nucleus in normal and pathological conditions. In: Pecheron G, McKenzie JS, Féger J, editors. The basal ganglia IV. New York: Plenum Press, 1994: 365-70.
65. Rimvall K, Martin DL. The level of GAD67 protein is highly sensitive to small increases in intraneuronal gamma-aminobutyric acid levels. J Neurochem 1994; 62: 1375-81.
66. Robledo P, Féger J. Excitatory influence of rat subthalamic nucleus. III. Changes in motor behaviour and neural activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1991; 72: 521-30.
67. Ryan LJ, Sanders DJ. Subthalamic nucleus lesion regularizes firing patterns in globus pallidus and substantia nigra pars reticulata neurons in rats. Brain Res 1993; 626: 327-31.
68. Sellai F, Hirsch E, Lisovoski F, Mutschler V, Collard M, Marescaux C. Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 1992; 42: 255-66.
69. Shantha TR, Manocha SL, Bourne GH. A stereotaxic atlas of the Java monkey brain (Macaca irus). Basel: Karger, 1968.
70. Strada O, Vyas S, Hirsch EC, Ruberg M, Brice A, Agid Y, et al. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Proc Natl Acad Sci USA 1992; 89: 9549-53.
71. Strominger NL, Carpenter MB. Effects of lesions in the substantia nigra upon subthalamic dyskinesia in the monkey. Neurology 1965: 15: 587-94.
72. Szabo J, Cowan WM. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J Comp Neurol 1984; 222: 265-300.
73. Vacca LL. 'Double bridge' techniques of immunocytochemistry. In: Bullock GR, Petrusz P, editors. Techniques in immunocytochemistry, Vol. 1. London: Academic Press. 1982: 155-82.
74. Vidakovic A, Dragasevic N, Kostic VS. Hemiballism: report of 25 cases [see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 945-9. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 645-7.
75. Vidakovic A, Dragasevic N, Kostic VS. Hemiballism: report of 25 cases [see comments]. J Neurol Neurosurg Psychiatry 1994; 57: 945-9. Comment in: J Neurol Neurosurg Psychiatry 1995; 58: 645-7.
76. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994a; 72: 521-30.
77. Wichmann T, Baron MS, DeLong MR. Local inactivation of the sensorimotor territories of the internal segment of the globus pallidus and the subthalamic nucleus alleviates parkinsonian motor signs in MPTP treated monkeys. In: Percheron G, McKenzie JS, Féger J, editors. The basal ganglia IV. New York: Plenum Press, 1994b: 357-63.